Versant Capital Management, Inc Takeda Pharmaceutical CO LTD Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Versant Capital Management, Inc holds 24,996 shares of TAK stock, worth $378,189. This represents 0.06% of its overall portfolio holdings.
Number of Shares
24,996
Previous 25,130
0.53%
Holding current value
$378,189
Previous $373,000
3.49%
% of portfolio
0.06%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding TAK
# of Institutions
362Shares Held
67.3MCall Options Held
1.72MPut Options Held
186K-
Capital Research Global Investors Los Angeles, CA13.2MShares$200 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.7MShares$86.3 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY5.32MShares$80.5 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.5MShares$53 Million0.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.43MShares$51.9 Million0.1% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $47B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...